Osteoclasts are unique multinucleated cells formed by fusion of preosteoclasts derived from cells of the monocyte/ macrophage lineage, which are induced by RANKL. However, characteristics and subpopulations of osteoclast precursor cells are poorly understood. We show here that a combination of TNF-a, TGF-b, and M-CSF efficiently generates mononuclear preosteoclasts but not multinucleated osteoclasts (MNCs) 
Introduction
Osteoclasts are bone-resorbing multinucleated cells that originate from multipotent hematopoietic stem cells in bone marrow [1, 2] . Early osteoclast precursor cells originate from cells of the monocyte/macrophage lineage. Osteoclast precursor cells differentiate into mononuclear preosteoclasts. Differentiated preosteoclasts fuse to form multinucleated osteoclasts. Osteoclasts are then activated to become mature osteoclasts having bone resorption activity. Receptor activator of NF-kB ligand (RANKL) and macrophage-colony-stimulating factor (M-CSF) are essential factors driving differentiation into mature osteoclasts from osteoclast precursors [3, 4] . These two factors bind to their respective receptors, RANK and c-fms, on the osteoclast precursor cell surface, and activate downstream signals such as Fos and nuclear factor of activated T cells c1 (NFATc1) [5] . The addition of RANKL with M-CSF to in vitro cultures of bone marrow cells or bone marrow macrophages (BMM) sequentially induces their differentiation into preosteoclasts and then to osteoclasts. However, because the culture contains osteoclasts, preosteoclasts, and their precursor cells, it is difficult to analyze characteristics of osteoclast precursor cells, per se.
Fusion of preosteoclasts during osteoclastogenesis is a critical process for bone resorption. It has been shown that several membrane proteins including CD9, cadherin, a member of the ADAM (disintegrin and metalloenzyme) family, and DC-STAMP (dendritic cell-specific transmembrane protein) are involved in multinucleation in osteoclastogenesis [6, 7, 8, 9] . Gene targeting of DC-STAMP in mice results in markedly increased bone mass because of impaired osteoclast fusion. On the other hand, recent findings indicate that CC chemokine receptors CCR1 and CCR2 are involved in fusion during osteoclastogenesis. Osteoclastognesis from CCR1 knockout mice was impaired due to a defect in multinucleation [10] , and a CCR1 inhibitor MLN3897 inhibited the fusion of human osteoclast precursor cells [11] . We and others previously reported that CCR1 and CCR2 ligands such as macrophage inflammatory protein-1a (MIP-1a) and monocyte chemoattractant protein-1 (MCP-1) stimulated RANKL-induced differentiation and fusion during osteoclastogenesis [12, 13] . Parathyroid hormone induced expression of MCP-1 in osteoblasts, which promoted fusion of osteoclasts [14] . However, the mechanism of osteoclast fusion remains unclear. It is also not known how the expression of these genes is regulated during differentiation of precursor cells into multinucleated cells.
Cell surface proteins are useful for identifying preosteoclasts. It has been shown that the phenotype of early-stage mouse osteoclast precursor cells is c-fms + /RANK 2 [15] . M-CSF stimulated these precursor cells to differentiate into c-fms + /RANK + late osteoclast precursor cells, which can then differentiate into osteoclasts in the presence of M-CSF and RANKL. However, BMM are also cfms
+ , and detailed characteristics of c-fms
+ osteoclast precursor cells are not well known. We have established mAb Kat1, which recognizes a surface antigen expressed on osteoclasts in rat bone marrow culture systems and in vivo [16, 17] .
We have reported that Kat1 antigen is specifically expressed by cells of the osteoclast lineage, and formation of Kat1 + cells was consistent with osteoclast differentiation [18, 19, 20, 21, 22] . In addition, expression of Kat1 antigen closely correlated with that of the calcitonin receptor in preosteoclasts and osteoclasts. Kat1 antibody reacted not only to osteoclasts formed in vitro but also osteoclasts in situ [17, 23] .
Previous studies have shown that TNF-a induced osteoclast formation from RANKL-primed or TGF-b-primed mouse BMM in a RANKL-RANK independent manner in vitro [24, 25] . We have previously developed a rat culture system in which preosteoclasts are formed from bone marrow cells deprived of stromal cells [20, 26] . In the culture system, TNF-a enhanced the formation of preosteoclasts in the presence of osteoblast conditioned medium, but TNF-a alone did not induce the formation of preosteoclasts [19] . In the current study, we show that TNF-a in combination with TGF-b in the presence of low concentrations of M-CSF efficiently generates preosteoclasts that express osteoclastspecific genes and Kat1 antigen in vitro. In addition, we found that preosteoclasts induced by TNF-a and TGF-b represented a late stage of differentiation, and we found that expression of CCR1 was not induced in preosteoclasts, but was induced during multinucleation.
Materials and Methods

Animals and Chemicals
FCS was purchased from BioWhittaker (Walkersville, MD). Recombinant human sRANKL, M-CSF, and OPG were from Pepro-Tech (London, United Kingdom). Recombinant rat TNFa and human TGF-b were purchased from Boehringer Mannheim (Mannheim, Germany) and R&D Systems (Minneapolis, MN), respectively. Rabbit anti-fms/CSF-1 receptor antibody was obtained from Upstate (Billerica, MA). Unlabeled anti-rat CD11b/c and Alexa Flour 488 mouse anti-rat CD11b/c (OX-42) were obtained from Biolegend (San Diego, CA). Mab Kat1 was prepared in our laboratory as described previously [17] . Biotin labeling kit was obtained from GE Healthcare. Goat anti-rabbit Alexa Fluor 488 and anti-mouse Alexa Fluor 568 antibodies were obtained from Molecular Probes. FITC-conjugated Streptavidin was obtained from eBioscience (San Diego, CA). MIP-1a, and MCP-1 were obtained from Invitrogen (CA, Carlsbad). Male Sprague Dawley (SD) rats (aged 7-10 weeks) were purchased from Kyudo Co. (Saga, Japan).
Ethics Statement
All experiments were reviewed and approved by the Laboratory Animal Care and Use Committee of Saga University, permit number (21-006-0), and Kyushu University, permit number (A23-083-0).
Formation of BMM, Preosteoclasts, and Osteoclasts (MNCs) in Rat Bone Marrow Cultures
Cultures of rat bone marrow cells were carried out as described by Kukita et al. [26] . Briefly, stromal cells were depleted by passage through a Sephadex G-10 column, and the nonadherent bone marrow cells (NABMCs) were recovered. To form preosteoclasts, NABMCs were cultured in the presence of various concentrations of TNF-a, TGF-b, and M-CSF for 2 to 3 days. In some experiments, combinations of RANKL, MIP-1a, and MCP-1 were added after 2 days of culture, and cells were cultured for an additional 2 to 3 days to induce MNCs. To form BMM, NABMCs were cultured in the presence of M-CSF (3 ng/ml) for 3 days. At the end of the culture, the cells were fixed and stained with a commercial kit for the osteoclast marker tartrate-resistant acid phosphatase (TRAP) (Sigma). TRAP + cells with 3 or more nuclei were counted as MNCs. For immunostaining for Kat1 mAb, bone marrow cells were cultured in the presence of 10 28 M 1,25(OH) 2 D 3 to form osteoclasts as described [27] .
RT-PCR and Real-time RT-PCR
Total RNA was extracted using Isogen (Nippon Gene), according to the manufacturer's protocol. cDNA was synthesized from 1 mg total RNA using random primers, avian myeloblastosis virus RT, and a PrimeScript RT-PCR kit (Takara Bio, Inc. Shiga, Japan). The primers used for RT-PCR and real-time RT-PCR analysis are shown in Table 1 . PCR was performed using Quick HS Taq DyeMix (Toyobo). PCR products were separated on a 1.5% agarose gel and stained with ethidium bromide. As an internal control for RNA quantity, the same cDNA was amplified using primers specific for rat actin mRNA. The intensity of bands was quantified by densitometry using ImageJ software (NIH). Real-time RT-PCR reactions were performed using a TaqMan gene expression assay kit or SYBR Premix Ex Taq (Takara Bio, Inc. Shiga, Japan) with a StepOnePlus real-time PCR system (Applied Biosystems, Foster City, CA). Reactions were conducted in a 10 ml reaction mixture and were incubated 1 minute at 95uC, followed by 40 cycles of a two-step amplification procedure composed of annealing/extension for 34 seconds at 60uC and denaturation for 5 seconds at 95uC. mRNA levels were quantified using a standard curve generated with serially diluted cDNA and normalized to Gapdh expression. A commercially available probeprimer set (Applied Biosystems) with proprietary sequences was used in PCR reactions for csf-1r (c-fms).
Immunochemistry and Immunofluorescence of in vitro Culture
Cells were stained for Kat1 as described [16] . Briefly, cells were incubated with Kat1 mAb for 30 minutes and then fixed with 4% paraformaldehyde, and blocked in 3% normal goat serum. For immunochemistry, the cells were incubated with biotin-conjugated anti-mouse IgM, and detected using an ABC-AP kit (Vector Laboratory) according to the manufacturer's protocol. 
Flow Cytometry
FACS analysis was performed as described with some modification [21] . NABMCs were cultured in the presence of M-CSF (3 ng/ml), TNF-a (20 ng/ml), and TGF-b (1 ng/ml) for 2 days. The cells were detached from the dish with 0.02% EDTA in PBS, and blocked with anti-FcR CD16/32 antibody (eBioscience) for 60 minutes. The cells were then incubated with biotin-conjugated Kat-1 mAb for 30 minutes. After three washes with a-MEM, 1% FCS, 10 mM EDTA, the cells were incubated with FITCconjugated streptavidin (eBioscience). Immunofluorescence was analyzed using a FACSCalibur analyzer (Becton Dickinson). Irrelevant mouse biotin-labeled IgM antibody (Beckman) was included as a control.
Panning of Kat
+ Cells
NABMCs were cultured in the presence of M-CSF (3 ng/ml), TNF-a (20 ng/ml), and TGF-b (1 ng/ml) for 2 days. The cells were detached from the dish with 0.02% EDTA in PBS, and Kat1 mAb was added to the cells. Preosteoclasts coated with Kat1 mAb were then added to a petri dish coated with anti-mouse IgG and incubated at 4uC for 60 minutes with gentle mixing. After nonbound cells were recovered, cells bound to the coated dishes were isolated by flushing out using a pipette. The cells were then seeded in 96-well plates at a density of 1610 5 cells/well, and incubated for 2 days in the presence of M-CSF (3 ng/ml) and RANKL (30 ng/ ml) to form MNCs.
Cell Migration Assays
Chemotaxis assays were performed using a transwell chamber (pore size, 8 mm, Becton Dickinson Labware, NJ) as described with some modification [28] . NABMCs were cultured in the presence of TNF-a together with TGF-b for 3 days. The cells were detached from the dish, and suspended in PBS containing 0.1% BSA. The cells were loaded into the upper side of 24-well transwell inserts, and then placed above lower chambers containing various concentrations of MCP-1 or MIP-1a in a -MEM with 10% FCS. Cells were allowed to migrate for 4 hours at 37uC followed by fixation in 4% formaldehyde and staining with hematoxylin. The number of cells that migrated to the lower side of the filter was determined by microscopy.
Induction of Adjuvant Arthritis (AA) in Rats
Female Lewis rats (Kyudo, Tosu, Japan) at 5 weeks old were, sedated under deep ether anesthesia, and intradermally injected at the base of the tail with complete adjuvant consisting of 25 mg/kg heat-killed Mycobacterium butyricum suspended in mineral oil as described [28] . The rats were housed in a 12-hour light/dark cycle with free access to water and chow. After twenty days, arthritis was assessed by observation of swelling.
Immunohistochemistry of Bone Tissues of Rats
Before harvesting synovial tissues, living osteoclasts were stained in situ by direct injection of Kat1 mAb into rats as described [17] . Briefly, the ammonium sulfate-precipitated fraction of Kat1 mAb ascites was injected intraperitoneally into rats. Twelve hours after the injection, the animals were perfused through the left ventricle with 4% paraformaldehyde followed by dissection of the hind paw (tarsal bones and tibia). After further fixation overnight at 4uC, bone tissues were decalcified by treatment with EDTA for 3 weeks at 4uC with gentle shaking. After washing with PBS, tissue blocks were immersed in 5% sucrose/PBS, 4uC for 4 hours, followed by immersion in 10% sucrose/PBS, 4uC for 4 hours. These blocks were further immersed in 20% sucrose/PBS, 4uC overnight and embedded in Tissue-Tek O.C.T compound (Sakura, Tokyo, 
Results
TNF-a in Combination with TGF-b induces Preosteoclasts at a Low Concentration of M-CSF in Rat Bone Marrow Culture Depleted of Stromal Cells
We first examined whether either TNF-a or TGF-b alone, or TNF-a together with TGF-b induced mononuclear osteoclast precursor cells at various concentrations of M-CSF. At 3 ng/ml M-CSF, TNF-a or TGF-b alone did not markedly induce the formation of TRAP + mononuclear cells (Fig. 1A) . However, TNFa together with TGF-b induced significantly greater formation of TRAP + mononuclear cells, but did not induce the formation of TRAP + multinucleated cells (MNCs) (Fig. 1A , and B top). In this culture, the intensity of TRAP staining was strong, and the percentage of TRAP + mononuclear cells in total cells was high (Fig. 1B, top) . Addition of RANKL (30 ng/ml) 2 days after addition of TNF-a, TGF-b, and M-CSF (3 ng/ml) to the culture induced the formation of TRAP + MNCs (Fig. 1B, middle) , indicating that TRAP + mononuclear cells are osteoclast precursor cells. Various concentrations of RANKL and M-CSF were tested in rat bone marrow cultures, and we determined the concentrations that induced preosteoclasts but not MNCs. A low concentration of RANKL (3 ng/ml) in the presence of M-CSF (10 ng/ ml) also induced the formation of TRAP + mononuclear cells but not TRAP + MNCs; however, the culture included a number of TRAP 2 mononuclear cells (Fig. 1B, bottom) . These results suggest that TNF-a and TGF-b efficiently induce an enriched population of mononuclear osteoclast precursor cells in rat bone marrow cultures at a low concentration of M-CSF (3 ng/ml). At a higher concentration of M-CSF (30 ng/ml), TNF-a together with TGFb induced formation of TRAP + MNCs (data not shown). To analyze characteristics of mononuclear osteoclast precursor cells induced by TNF-a and TGF-b, we compared expression of several osteoclast-specific genes and genes encoding a number of cell surface proteins in the culture of osteoclast precursor cells with that in the cultures of BMM and MNCs by semi-quantitative RT-PCR analysis ( Fig. 1D and E) . Treatment with TNF-a together with TGF-b strongly increased the expression of not only cathepsin K (ctsk), but also calcitonin receptor (calcr), NFATc1 (nfatc1), and c-fos compared to BMM. As shown in Fig. 1F , realtime RT-PCR analysis showed that the expression of ctsk and DC-STAMP (tm7sf4) was significantly increased in preosteoclasts compared to BMM and further increased in MNCs. On the other hand, c-fms (csf-1r) and RANK (tnfrsf11a) were expressed in the cultures of preosteoclasts at almost the same level as BMM, but expression of csf-1r was decreased in MNCs ( Fig. 1E and F ). These results demonstrate that TRAP + mononuclear cells induced by TNF-a and TGF-b are mononuclear osteoclasts, i.e., preosteoclasts.
Characterization of Preosteoclasts with an Osteoclastspecific mAb Kat1
To analyze preosteoclasts induced by TNF-a and TGF-b in detail, we next used Kat1 mAb which specifically recognizes osteoclasts and osteoclast precursor cells in rats. Kat1 stained osteoclasts formed in rat bone marrow culture in vitro. We have reported that viable osteoclasts can be detected in situ in mandible tissues of newborn rats by injecting into the peritoneal cavity of rats [17] . As described previously, osteoclasts formed in vitro and present on rat mandible bone in vivo were detected by Kat1 mAb ( Fig. 2A and B) . Analysis with confocal laser microscopy showed that TNF-a and TGF-b induced the formation of Kat1 + mononuclear cells in the presence of M-CSF, and Kat1 antigen was localized on the cell membrane of preosteoclasts (Fig. 2C,  right) . In contrast, Kat-1 + cells were not detected in BMM (Fig. 2C,  left) . In addition, FACS analysis also showed that Kat1 antigen is expressed on the cell surface of preosteoclasts induced by TNFa and TGF-b, but is not expressed on BMM (Fig. 2D) .
To analyze the population of preosteoclasts induced by TNFa and TGF-b in more detail, we next performed double staining of cells with Kat1 and anti-c-fms antibodies. TNF-a alone increased the population of single-positive Kat1 (Fig. 3A and B) . In contrast, treatment with TNF-a and TGF-b did not increase the formation of Kat1 2 c-fms + cells. Thus, TNF-a combined with TGF-b preferentially generated subpopulations of Kat1 + preosteoclasts, especially Kat1 + c-fms + cells.
Analysis of the Differentiation Status of Preosteoclast Subpopulations Induced by Various Combinations of TNF-a and TGF-b
To analyze differentiation stages of preosteoclast subpopulations, we performed a time course analysis of cell surface expression of Kat1 antigen and c-fms using the cell population induced by TNF-a (20 ng/ml) and TGF-b (1 ng/ml) (Fig. 4A) . Kat1 2 c-fms + cells appeared in the early stage (48 hours) of culture and their numbers decreased thereafter (Fig. 4B) (Fig. 4C) .
We further analyzed the differentiation ability of the preosteoclasts induced by TNF-a and TGF-b. As shown in Fig. 1B , after formation of preosteoclasts by TNF-a and TGF-b, the addition of RANKL to the culture generated TRAP + MNCs. We then analyzed the time course of RANKL-mediated formation of TRAP + MNCs from cells induced by various conditions (Fig. 5A ). TRAP + MNCs were generated from preosteoclasts induced by TNF-a plus TGF-b within 1 day after addition of RANKL. In contrast, the number of TRAP + MNCs generated from BMM or cells induced by TNF-a alone was increased at 3 days after addition of RANKL. In addition, hydroxyurea, which inhibits DNA synthesis, did not inhibit the formation of TRAP + MNCs from preosteoclasts induced by TNF-a plus TGF-b (Fig. 5B) . These data suggest that cells induced by TNF-a and TGF-b, 
Analysis of Expression of Surface Proteins in Preosteoclasts and MNCs
To characterize preosteoclasts induced by TNF-a and TGF-b in more detail, we used real-time RT-PCR analysis to compare expression levels of several genes encoding surface proteins among cells induced by various conditions (Fig. 6A) . The expression of emr1 (F4/80) a macrophage marker was decreased in preosteoclasts induced by TNF-a plus TGF-b. Treatment with TGFb alone resulted in markedly reduced expression of emr1 in comparison with BMM. On the other hand, no significant difference was seen in the mRNA expression levels of the monocyte marker, CD11b (itgam) between preosteoclasts and BMM (Fig. 6 A) (Fig. 6B and C) . Thus, Kat1 + CD11b/c + cells were induced by TNF-a and TGF-b, but also TNF-a alone.
To examine the expression of surface proteins of preosteoclasts in more detail, we analyzed the expression of chemokine receptors CCR1, CCR2, and CCR5, which are involved in osteoclastogenesis. The expression of CCR1 was decreased in cells treated with TNF-a or TGF-b alone, and was not upregulated in preosteoclasts. Interestingly, however, CCR1 expression was markedly increased in MNCs induced by RANKL (Fig. 6A) . On the other hand, the expression of TGF-b, and M-CSF, and cultures were continued for 2 days. At the end of culture, TRAP-staining was performed and TRAP + mononuclear cells were counted. Total RNA from cells was prepared and analyzed by semi-quantitative RT-PCR or real-time RT-PCR using specific primers as in Materials and Methods. Each value represents the mean 6 SEM (n = 3). Statistical significance was determined by Student's t test; *P,0.05, **P,0.01 compared with BMM. Experiments were performed three times using three different rats, and similar results were obtained. doi:10.1371/journal.pone.0047930.g001 CCR2 was low, and was not changed among BMM, preosteoclasts or MNCs. In contrast, CCR5, which was highly expressed in BMM, was decreased in preosteoclasts and MNCs. Thus, using preosteoclast cultures induced by TNF-a and TGFb, it was found that itgam, CCR1, and CCR2 were neither down-regulated nor up-regulated in preosteoclasts, but expression of emr1 and CCR5 were down-regulated in preosteoclasts. In addition, comparison of preosteoclasts and MNCs showed that CCR1 expression was markedly increased in the multinucleation step during osteoclastogenesis.
MIP-1a and MCP-1 Promote RANKL-induced Multinucleation of Preosteoclasts
The results from expression analysis of chemokine receptors CCR1 and CCR2 in preosteoclasts suggested that preosteoclasts would exhibit chemotactic activity toward the chemokine ligands, MIP-1a and MCP-1. To asses this possibility, we examined migration activity of preosteoclasts toward MIP-1a and MCP-1. Cell migration toward MIP-1a and MCP-1 increased in a dose-dependent fashion (Fig. 7A and B) . To determine if CCR1 and CCR2 were involved in multinucleation from preosteoclasts, we analyzed the effect of MIP-1a and MCP-1 on formation of TRAP + MNCs from preosteoclasts in the presence of RANKL and M-CSF. Both MIP-1a and MCP-1 significantly stimulated RANKL-induced fusion of preosteoclasts, specifically inducing large multinucleated cells having more than 5 nuclei (Fig. 7C) . To determine whether Kat1 and c-fms double positive cells were present in vivo, we performed Kat1 mAb in situ immunostaining of bone tissues obtained from ankle joints of AA rats. We first injected Kat1 mAb into AA rats, and later immunostained bone tissues with anti-c-fms antibody or stained for TRAP. Double-positive cells were detected in the site of bone destruction in distal tibia. Kat1
+ cells present in the bone surface also expressed c-fms (Fig. 8A, arrow heads) , and were also positive for TRAP (Fig. 8B) . In the bone marrow area, one pair of cells positive for both Kat1 antigen and c-fms can be seen (Fig. 8A, arrow) . These data demonstrate the presence of Kat1 + c-fms + cells in bone tissue accompanying inflammatory bone destruction. 
Discussion
Although the molecular mechanisms regulating osteoclast differentiation from hematopoietic precursors and the essential role of RANKL has been well described, relatively little is known about characteristics and subpopulations of osteoclast precursor cells and preosteoclasts. Bone marrow cells and BMM are widely utilized to form osteoclasts by treatment with 1,25(OH) 2 D 3 or RANKL in vitro [29] . However, because most in vitro culture systems induce osteoclasts without arresting cells at the stage of preosteoclasts, it is difficult to investigate the characteristics of osteoclast precursors and preosteoclasts. In addition, most such cultures include large numbers of undifferentiated cells and cells of lineages unrelated to osteoclasts. We also found that the percentage of preosteoclasts in total cells was not increased by use of various concentrations of RANKL and M-CSF in rat bone marrow culture. Here, we demonstrate that the combination of TNF-a and TGF-b efficiently induces the formation of preosteoclasts, which express osteoclast-specific genes and the osteoclastspecific antigen, Kat1, and comprised 50-60% of total cells in the culture.
Osteoclast precursor cells, monocytes, and macrophages are heterogeneous populations. In mouse monocytes, there are classical inflammatory monocytes and non-classical monocytes that play different roles in inflammation [30] . The short-lived CCR2
+
Gr1
2 subset is actively recruited to inflamed tissues, whereas the CCR2 2 Gr1 + subset is recruited to non-inflamed tissues in a CX 3 CR1-dependent manner. CD14 and CD16 are utilized to define human monocyte subsets, including the CD14 + CD16 2 and CD14 lo CD16 + subsets, which have different roles and homing potentials [31] . Macrophages are also classified into M1 and M2 macrophages, which are functionally differentially polarized in response to microorganisms and host mediators [32] . It has been reported that some populations of monocytes have differential potentials to differentiate into osteoclasts. The CD16 2 human blood monocyte subset, but not the CD16 + monocyte subset, differentiates into osteoclasts when treated with RANKL and M-CSF [33] . However, it is still poorly understood that among preosteoclasts-more differentiated osteoclast precursor cells-there may be distinct subsets (phenotypic diversity). Cell surface markers such as c-fms, RANK, and CD11b have been used to identify mouse osteoclast precursor cells, but these markers are also expressed on macrophages. To characterize preosteoclasts in details, it is necessary to use unique cell surface markers to characterize them. Therefore, we used Kat1 mAb which specifically detects cells of the osteoclast lineage. The Kat1 antigen is different from the calcitonin receptor and RANK, but its distribution is similar to that of the calcitonin receptor [17, 18] , indicating that Kat1
+ cells are in a more differentiated stage. In this study, we have shown that combined use of c-fms or CD11b along with Kat1 mAb was useful for analyzing preosteoclasts.
Using + antigen and preosteoclasts populations is necessary.
Several reports indicate that osteoclast precursor cells express CD11b [15, 29] . In our study, preosteoclasts induced by TNFa and TGF-b expressed CD11b at levels similar to BMM, and some populations of CD11b + cells were Kat1 + CD11b 2 cells. The results suggest that specific population of preosteoclasts may be induced in inflammatory conditions. TNF-a-transgenic mice developed erosive arthritis, and the number of osteoclasts precursors in blood and inflamed joints was increased. [34, 35] . In the transgenic mice, TNFa increased the number of CD11b high osteoclast precursor cells, which may differ from normal monocytes, and may represent a specific population of osteoclast precursor cells. Consistent with these results, when we analyzed Kat1
+
CD11b
+ cells in bone marrow cells of AA rat, the number of Kat1 + CD11b + cells was significantly increased in comparison to the numbers in control rats (A. Kukita et al. unpublished data + cells were used to track migration of osteoclast precursor cells from blood into bone [36] . Similar use of an osteoclast-specific antibody such as Kat1 in concert with c-fms or CD11b should give us more details of properties of osteoclast precursor cells accumulating in inflammatory disease sites.
In this study, we used TNF-a and TGF-b to induce preosteoclasts, but found that TNF-a and TGF-b have distinct roles in osteoclastogenesis. TNF-a alone induced a small number of TRAP-positive cells, which expressed osteoclast-specific genes and Kat1
In contrast, TGF-b did not efficiently induce osteoclastogenesis. However, TGF-b strongly inhibited the expression of emr-1. Emr-1 encodes the F4/80 antigen, which is specifically expressed in macrophages. It has been shown that TGF-b stimulates or inhibits osteoclastogenesis depending on the in vitro culture system, and also promotes apoptosis of osteoclasts [37, 38] . Several recent reports have shown that TGF-b directly affects osteoclast signaling in cells of the osteoclast lineage, and stimulates osteoclastogenesis, particularly early in the differentiation pathways [39, 40] . Our data suggest that the stimulatory activity of TGF-b on osteoclastogenesis may also be mediated by inhibiting differentiation into macrophages.
Interestingly, we found that expression of chemokine receptors is regulated during differentiation from BMM to preosteoclasts and MNCs. Although expression of osteoclast-specific genes such as cathepsin K was up-regulated in preosteoclasts, expression of CCR1 was not up-regulated. However, CCR1 expression was markedly increased in MNCs induced by RANKL. CCR1, which is a receptor for MIP-1a, is up-regulated by RANKL, and is involved in the function of osteoclasts and cell-fusion of osteoclasts [10, 13, 41] . Recently, it has been reported that the CCR1 gene was a target of NFATc1 [41] . However, the timing of the induction of CCR1 in osteoclastogenesis is not clear. Our results 
c-fms
+ cells are present in bone tissues obtained from AA rats. Immunofluorescence images of Kat1 antigen (red) and c-fms (green) (A), and different interference contrast (DIC) and TRAP staining (B) of bone tissues obtained from ankle joint of AA rats are shown. Living osteoclasts were stained in situ by the direct injection of the Kat1 mAb, and rats were perfused with 4% paraformaldehyde followed by dissection of the hind paw. Frozen sections were prepared as in Materials and Methods. Tissue sections were then stained with c-fms antibody, followed by treating with Alexa Fluor 568-conjugated goat anti-mouse IgG and 488-conjugated anti-rabbit IgG. The same section was also stained for TRAP. B, bone; BM, bone marrow. Bar = 20 mm. Arrow heads and arrow indicate Kat1 show that the induction of CCR1 expression occurs during fusion. The results suggest that the therapeutic regulation of CCR1 expression and function may be useful for controlling bone resorption. Consistent with our data, it was very recently reported that CCR1 blockade efficiently blocked osteolysis in a mouse model of myeloma bone disease [42] . We also found that a CCR1 ligand, MIP-1a, was chemotactic for preosteoclasts, and stimulated fusion. CCR2, which is a receptor for MCP-1, and is abundantly expressed in macrophages, has recently been found to be up-regulated in CD11b high osteoclast precursor cells [43] . Ablation of the CCR2 gene results in a defect in osteoclastogenesis. In our study, expression of CCR2 was low, and was not upregulated in preosteoclasts and MNCs. However, preosteoclasts expressed CCR2, and MCP-1 was also chemotactic for preosteoclasts, and stimulated fusion, suggesting that CCR2 is also involved in osteoclastogenesis. On the other hand, the expression of CCR5, which was abundantly expressed in macrophages, was down-regulated during differentiation into preosteoclasts and osteoclasts, suggesting that CCR5 may not be involved in osteoclastogenesis.
In the present study, we show that a combination of TNF-a and TGF-b preferentially directs osteoclast differentiation and increases Kat1
+ c-fms + preosteoclasts, which express several osteoclast-specific genes. In our comparison of preosteoclasts with BMM and osteoclasts, we found that preosteoclasts have unique characteristics. CD11b, CCR1, and CCR2 were expressed in preosteoclasts, but only CCR1 expression was markedly increased during fusion. The identification of preosteoclasts will be useful for investigating the origin and the trafficking of preosteoclasts formed in normal bone and in inflammatory disease. In addition, identification of surface proteins that are differentially expressed in preosteoclasts and MNCs may prove useful in controlling the fusion step in osteoclastogenesis and bone resorption.
